News & Updates

For vulnerable cancer patients undergoing chemotherapy, treatment with low-dose olanzapine works just as well as megestrol acetate in terms of promoting appetite and weight gain, as shown in a study.

Nonmetastatic breast cancer survivors who are genetically predisposed to having an excess body weight appear to be at increased risk of mortality, as shown in a study.

Sentinel lymph node biopsy (SLNB) may be safely omitted after breast-conserving therapy in patients with early-stage, node-negative breast cancer, with 5-year data from the BOOG 13-08 trial showing no difference in regional recurrence-free and distant disease-free survival outcomes whether or not SLNB was performed.

A recent study has shown the capacity of a novel prognostic model in predicting the long-term risk for prostate cancer-specific mortality (PCSM) following a prostate-specific antigen (PSA) test.

For young women with a pathogenic variant in BRCA1 or BRCA2, initiating hormone replacement therapy following surgical menopause does not appear to significantly increase the risk of breast cancer, with oestrogen-alone therapy even conferring protection, according to a study.